4/11/2008

Researchers at Washington University in St. Louis have devised a nanoparticle system that can directly deliver fumagillin, a chemotherapeutic agent, to blood vessels that feed tumors without harming healthy tissues. The nanoparticles include two types of molecules -- one for imaging and the other for targeting.

Related Summaries